HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vincent Soriano Selected Research

Antiviral Agents (Antivirals)

3/2015Drug interactions with new hepatitis C oral drugs.
1/2014Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.
9/2013Update on HIV/HCV coinfection.
2/2013Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver.
1/2013The changing epidemiology of liver disease in HIV patients.
1/2013The changing face of hepatitis C in the new era of direct-acting antivirals.
2/2012Treatment failure with new hepatitis C drugs.
11/2011Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients.
8/2011Directly acting antivirals against hepatitis C virus.
7/2008Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Vincent Soriano Research Topics

Disease

61Infection
09/2015 - 01/2002
50Chronic Hepatitis C
03/2015 - 01/2002
27HIV Infections (HIV Infection)
01/2015 - 10/2002
26Hepatitis C
10/2013 - 01/2004
23Liver Cirrhosis (Hepatic Cirrhosis)
01/2015 - 07/2004
18Viremia
08/2013 - 07/2003
17Chronic Hepatitis B
11/2013 - 02/2005
13Fibrosis (Cirrhosis)
01/2015 - 09/2002
12Hepatitis B
09/2015 - 10/2002
12Acquired Immunodeficiency Syndrome (AIDS)
09/2015 - 05/2002
10Liver Diseases (Liver Disease)
02/2011 - 12/2004
5Hepatitis
01/2013 - 01/2005
5Anemia
02/2012 - 08/2005
5End Stage Liver Disease
11/2011 - 07/2004
5Hypersensitivity (Allergy)
08/2010 - 05/2002
4Disease Progression
01/2015 - 04/2005
4Hepatitis D
10/2014 - 01/2011
4Hyperbilirubinemia
02/2009 - 01/2006
4Pancreatitis
09/2006 - 05/2003
4Lipodystrophy
07/2005 - 05/2002
3Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
07/2012 - 01/2003
3Spinal Cord Diseases
11/2007 - 01/2003
2Neoplasms (Cancer)
09/2015 - 03/2015
2Superinfection
04/2013 - 03/2010
2Hemolytic Anemia
02/2012 - 04/2010
2Portal Hypertension
05/2010 - 11/2008
2Diarrhea
02/2009 - 10/2003
2Dyslipidemias (Dyslipidemia)
02/2009 - 04/2008
1Hepatic Encephalopathy
01/2013
1Necrosis
11/2011
1Bacterial Infections (Bacterial Infection)
05/2011
1Communicable Diseases (Infectious Diseases)
03/2011
1Hypertension (High Blood Pressure)
10/2010

Drug/Important Bio-Agent (IBA)

40Ribavirin (Virazole)FDA LinkGeneric
01/2015 - 09/2002
39RNA (Ribonucleic Acid)IBA
01/2015 - 05/2003
36InterferonsIBA
01/2015 - 09/2002
28Carbon MonoxideIBA
09/2015 - 04/2002
13Antiviral Agents (Antivirals)IBA
03/2015 - 04/2006
10Lamivudine (3TC)FDA Link
11/2013 - 01/2003
10Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2013 - 12/2004
9tenofovirFDA Link
10/2014 - 01/2005
7Protease Inhibitors (Protease Inhibitor)IBA
01/2015 - 10/2002
7DNA (Deoxyribonucleic Acid)IBA
10/2014 - 03/2007
7Didanosine (Videx)FDA LinkGeneric
05/2010 - 05/2003
5AntibodiesIBA
04/2013 - 05/2004
5Nevirapine (Viramune)FDA Link
01/2010 - 01/2002
4MK 0518FDA Link
03/2013 - 10/2009
4abacavir (Ziagen)FDA Link
08/2010 - 11/2007
4efavirenz (Sustiva)FDA Link
01/2010 - 07/2003
4atazanavir (Reyataz)FDA Link
02/2009 - 01/2006
4AntigensIBA
11/2007 - 06/2005
4Stavudine (Zerit)FDA LinkGeneric
04/2007 - 03/2004
3telaprevirIBA
07/2013 - 09/2012
3Hepatitis B e AntigensIBA
10/2012 - 04/2007
3InterleukinsIBA
07/2012 - 11/2011
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2011 - 05/2003
3HLA-B Antigens (HLA-B)IBA
08/2010 - 11/2007
3lopinavir (Kaletra)FDA Link
02/2009 - 10/2003
3Alanine Transaminase (SGPT)IBA
01/2009 - 05/2002
3Interferon-alpha (Interferon Alfa)FDA Link
12/2008 - 06/2005
3TransaminasesIBA
01/2008 - 06/2006
3entecavirFDA Link
10/2007 - 06/2005
3adefovirIBA
05/2007 - 06/2005
3Mitochondrial DNA (mtDNA)IBA
03/2007 - 03/2004
3Zidovudine (Retrovir)FDA LinkGeneric
09/2006 - 05/2002
2Integrase InhibitorsIBA
03/2015 - 09/2008
2Hyaluronic Acid (Hyaluronan)IBA
01/2013 - 01/2011
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2013 - 09/2012
2inosine triphosphataseIBA
03/2012 - 12/2011
2Interleukin-7 (Interleukin 7)IBA
12/2011 - 11/2008
2IntegrasesIBA
04/2011 - 02/2010
2Surface Antigens (Surface Antigen)IBA
03/2011 - 04/2008
2maravirocFDA Link
12/2010 - 01/2010
2tipranavirFDA Link
07/2010 - 10/2009
2Hepatitis C AntibodiesIBA
03/2010 - 12/2004
2tenofovir disoproxil (Viread)FDA Link
01/2010 - 10/2006
2Reverse Transcriptase InhibitorsIBA
04/2007 - 11/2005
2enfuvirtide (Fuzeon)FDA Link
07/2005 - 05/2004
1VaccinesIBA
09/2015
1P-GlycoproteinIBA
03/2015
1HIV Protease InhibitorsIBA
01/2015
1Cytokine Receptors (Cytokine Receptor)IBA
01/2015
1Viral RNAIBA
10/2013
1Neutralizing AntibodiesIBA
02/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2013
1Biological Markers (Surrogate Marker)IBA
01/2013
1Non-alcoholic Fatty Liver DiseaseIBA
01/2013
1Rilpivirine (TMC-278)IBA
05/2012
1LDL CholesterolIBA
03/2012
1Inosine Triphosphate (ITP)IBA
02/2012
1DEBIO-025IBA
08/2011
1Interleukin-17 (Interleukin 27)IBA
05/2011

Therapy/Procedure

29Highly Active Antiretroviral Therapy (HAART)
03/2012 - 10/2002
4Therapeutics
09/2013 - 07/2008
2Aftercare (After-Treatment)
04/2011 - 11/2006
2Liver Transplantation
01/2010 - 07/2004
2Transplants (Transplant)
06/2005 - 01/2003
2Transplantation (Transplant Recipients)
06/2005 - 01/2003
1Drug Therapy (Chemotherapy)
09/2015
1Art Therapy
01/2011